Key stats
Market capitalization
2.698BUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.58USD
About Axsome Therapeutics, Inc
ISIN
US05464T1043
Sector
Health Technology
Industry
Biotechnology
Website
axsome.com
CEO
Herriott Tabuteau
Headquarters
New York
Employees
383
Founded
2012
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0